
معرفی
Professor Eiman Abdel Aleem serves as a Professor of Biomedical Science at London South Bank University (LSBU), where she established and directs the Biomedical Science programme while leading the Cancer Biology and Therapy research group. She joined LSBU in 2018 after holding research positions at the University of Arizona College of Medicine-Phoenix, Phoenix Children's Hospital, Karolinska Institutet, and the National Cancer Institute.
Her research focuses on identifying molecular drivers in cancer development and progression, with specific expertise in hypoxia-induced drug resistance in acute myeloid leukemia and nuclear IGF-1R functional interactions. She investigates obesity-cancer comorbidity mechanisms and nanoparticle-based therapeutic approaches, contributing significantly to UN Sustainable Development Goals through cancer research. Her work integrates molecular biology, bioinformatics, and translational methodologies including next-generation sequencing and 3D cell culture models.
Recent publication trends show increasing focus on microbiome-cancer interactions (2025), computational drug repurposing (2024), and geographical epidemiology of obesity-cancer relationships (2024). Her editorial roles include Associate Editor for Frontiers in Cell and Developmental Biology and board membership for Journal of Experimental & Clinical Cancer Research (IF 12.658) and Cancers (IF 6.102).
Professor Abdel Aleem directs 3 PhD students in projects spanning IGF-1R binding partners, nuclear IGF-1R functions, and microbiome health interactions (in collaboration with Weill-Cornell Qatar University). Her research group comprises 3 PhD scientists specializing in cancer molecular biology, molecular docking, epigenetics, and bioinformatics, supported by postgraduate students and technical staff. Major funding has been secured from Children Cancer Network, Phoenix Children’s Leadership Circle, European Commission, and Swedish Research Links for projects developing 3D bone-marrow models and investigating hypoxia-altered drug responses.
Her laboratory at LSBU features high-throughput drug screening systems, high-content imaging, flow cytometry, and Real-time QPCR instrumentation. She actively mentors international placement students and interns while serving as external PhD examiner and academic promotion assessor for global institutions.



